相似文献
1
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
Cancer Cell. 2011 Apr 12;19(4):541-55. doi: 10.1016/j.ccr.2011.02.006.
2
CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Tumour Biol. 2016 Mar;37(3):3461-8. doi: 10.1007/s13277-015-4172-x. Epub 2015 Oct 8.
3
Discovery of CCL18 antagonist blocking breast cancer metastasis.
Clin Exp Metastasis. 2019 Jun;36(3):243-255. doi: 10.1007/s10585-019-09965-2. Epub 2019 May 6.
4
Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
J Cell Biochem. 2014 Mar;115(3):596-603. doi: 10.1002/jcb.24697.
5
Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway.
Eur J Cancer. 2013 Dec;49(18):3900-13. doi: 10.1016/j.ejca.2013.07.146. Epub 2013 Aug 31.
6
CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Oncotarget. 2015 Oct 27;6(33):34758-73. doi: 10.18632/oncotarget.5325.
7
CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.
Mol Carcinog. 2016 Dec;55(12):2051-2062. doi: 10.1002/mc.22450. Epub 2016 Jan 12.
8
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Oncotarget. 2015 Aug 21;6(24):20485-99. doi: 10.18632/oncotarget.4107.
9
Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid.
Asian Pac J Cancer Prev. 2012;13(5):1877-80. doi: 10.7314/apjcp.2012.13.5.1877.
10
CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Oncol Rep. 2020 Feb;43(2):571-580. doi: 10.3892/or.2019.7426. Epub 2019 Dec 11.
引用本文的文献
1
Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.
Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2420793122. doi: 10.1073/pnas.2420793122. Epub 2025 Aug 20.
2
Inhibition of ARH2 by pH/ROS-responsive nanosystem for improved lung adenocarcinoma immunochemotherapy.
Bioact Mater. 2025 Aug 2;53:737-753. doi: 10.1016/j.bioactmat.2025.07.042. eCollection 2025 Nov.
3
Genetic evidence for causal effects of inflammatory protein factors on breast cancer.
Discov Oncol. 2025 Aug 7;16(1):1490. doi: 10.1007/s12672-025-03370-w.
4
Interpretable graph Kolmogorov-Arnold networks for multi-cancer classification and biomarker identification using multi-omics data.
Sci Rep. 2025 Jul 29;15(1):27607. doi: 10.1038/s41598-025-13337-0.
5
CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer.
Int J Breast Cancer. 2025 Jul 14;2025:8856457. doi: 10.1155/ijbc/8856457. eCollection 2025.
6
Peptide based vesicles for cancer immunotherapy: design, construction and applications.
Front Immunol. 2025 May 27;16:1609162. doi: 10.3389/fimmu.2025.1609162. eCollection 2025.
7
Tumor-associated macrophages-induced lncRNA RP11-627G18.1 promotes breast cancer metastasis.
Genes Immun. 2025 Jun 9. doi: 10.1038/s41435-025-00339-1.
8
Increased CCL18 expression infers a poor prognosis in glioblastoma multiforme and promotes U-87 MG cell proliferation and migration: A retrospective cohort study.
Medicine (Baltimore). 2025 May 30;104(22):e42009. doi: 10.1097/MD.0000000000042009.
9
USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells.
Oncogene. 2025 Apr 23. doi: 10.1038/s41388-025-03425-w.
10
Elasticity-Driven Nanomechanical Interaction to Improve the Targeting Ability of Lipid Nanoparticles in the Malignant Tumor Microenvironment.
Adv Sci (Weinh). 2025 Jul;12(26):e2502073. doi: 10.1002/advs.202502073. Epub 2025 Mar 27.
本文引用的文献
1
Chemokines and chemokine receptors: new insights into cancer-related inflammation.
Trends Mol Med. 2010 Mar;16(3):133-44. doi: 10.1016/j.molmed.2010.01.003. Epub 2010 Feb 15.
2
Macrophages, innate immunity and cancer: balance, tolerance, and diversity.
Curr Opin Immunol. 2010 Apr;22(2):231-7. doi: 10.1016/j.coi.2010.01.009. Epub 2010 Feb 9.
3
Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development.
Cell. 2010 Jan 22;140(2):268-79. doi: 10.1016/j.cell.2009.12.046.
4
Nuclear factor-kappaB and tumor-associated macrophages.
Clin Cancer Res. 2010 Feb 1;16(3):784-9. doi: 10.1158/1078-0432.CCR-09-1015. Epub 2010 Jan 26.
5
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.
Genes Dev. 2010 Feb 1;24(3):241-55. doi: 10.1101/gad.1874010. Epub 2010 Jan 15.
6
CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders.
Neuroscience. 2010 Feb 17;165(4):1233-43. doi: 10.1016/j.neuroscience.2009.11.050. Epub 2009 Dec 1.
7
Epithelial-mesenchymal transitions in development and disease.
Cell. 2009 Nov 25;139(5):871-90. doi: 10.1016/j.cell.2009.11.007.
8
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Med Oncol. 2010 Dec;27(4):1246-53. doi: 10.1007/s12032-009-9366-x. Epub 2009 Nov 24.
9
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.
J Leukoc Biol. 2009 Nov;86(5):1065-73. doi: 10.1189/jlb.0609385. Epub 2009 Sep 9.
10
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.
Cancer Cell. 2009 Aug 4;16(2):91-102. doi: 10.1016/j.ccr.2009.06.018.
Zotero 插件